Amarin Corporation plc
Amarin is a specialty pharma company focused on cardiovascular disease treatments with minimal direct political engagement and low government dependence.
BusinessWhat AMRN does
Amarin develops and commercializes prescription medicines for cardiovascular and metabolic diseases, primarily Vascepa (icosapent ethyl), a purified EPA omega-3 fatty acid. Revenue is driven by specialty pharma sales to hospitals, clinics, and retail pharmacies, with some Medicare/Medicaid reimbursement exposure.
Lifetime Government AwardsAMRN federal contracts
AMRN doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding AMRN
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting AMRNLive legislation impacting this stock
Political ProfileWhere AMRN sits in Washington
Amarin has minimal lobbying footprint and no measurable politician trading activity. Stock moves primarily on clinical trial results, FDA decisions, and reimbursement coverage—not legislative events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- Medicare negotiation expansion
- drug pricing caps
- FDA label restrictions
Regulatory opportunities
- Vascepa label expansion
- Medicare coverage expansion
- orphan drug incentives
Live signals + predictions for AMRN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades AMRN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord